TY  - JOUR
AU  - Vazquez-Borrego, Mari C
AU  - L-Lopez, Fernando
AU  - Galvez-Moreno, Maria A
AU  - Fuentes-Fayos, Antonio C
AU  - Venegas-Moreno, Eva
AU  - Herrera-Martinez, Aura D
AU  - Blanco-Acevedo, Cristóbal
AU  - Solivera, Juan
AU  - Landsman, Tanya
AU  - Gahete, Manuel D
AU  - Soto-Moreno, Alfonso
AU  - Culler, Michael D
AU  - Castaño, Justo P
AU  - Luque, Raul M
PY  - 2019
DO  - 10.1159/000500812
UR  - http://hdl.handle.net/10668/14215
T2  - Neuroendocrinology
AB  - Pituitary neuroendocrine tumors (PitNETs) represent approximately 15% of all intracranial tumors and usually are associated with severe comorbidities. Unfortunately, a relevant number of patients do not respond to currently available pharmacological...
LA  - en
PB  - S. Karger
KW  - Chimeric compound
KW  - Dopamine
KW  - Pituitary neuroendocrine tumors
KW  - Receptor
KW  - Somatostatin
KW  - Dopamine
KW  - Dopamine agents
KW  - Humans
KW  - Neuroendocrine tumors
KW  - Pituitary neoplasms
KW  - Somatostatin
KW  - Tumor cells, cultured
TI  - A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells.
TY  - research article
VL  - 110
ER  -